Equity Details
Price & Market Data
Price: $1.88
Daily Change: -$0.09 / 4.79%
Daily Range: $1.87 - $2.35
Market Cap: $8,457,509
Daily Volume: 673,279
Performance Metrics
1 Week: -6.93%
1 Month: -40.88%
3 Months: 86.14%
6 Months: -8.74%
1 Year: -68.67%
YTD: 59.32%
About bioAffinity Technologies, Inc. (BIAF)
Quick market take on bioAffinity Technologies, Inc. (BIAF). Current price: 1.88, daily change: -$0.09 / 4.79%. Market cap: 8,457,509. Performance over 1-week and 1-month.
Company Details
Employees: 57
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.